AbbVie Other Non-Current Liabilities 2012-2026 | ABBV

AbbVie other non-current liabilities for the quarter ending March 31, 2026 were $31.655B, a 4.17% decline year-over-year.

  • AbbVie other non-current liabilities for 2024 were $30.129B, a 6.8% decline from 2023.
  • AbbVie other non-current liabilities for 2023 were $32.327B, a 5.45% increase from 2022.
  • AbbVie other non-current liabilities for 2022 were $30.655B, a 6.81% increase from 2021.

AbbVie Other Non-Current Liabilities 2012-2026 | ABBV

  • AbbVie other non-current liabilities for 2024 were $30.129B, a 6.8% decline from 2023.
  • AbbVie other non-current liabilities for 2023 were $32.327B, a 5.45% increase from 2022.
  • AbbVie other non-current liabilities for 2022 were $30.655B, a 6.81% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B